SYNOFEPIM

This brand name is authorized in Nigeria.

Active ingredients

The drug SYNOFEPIM contains one active pharmaceutical ingredient (API):

1	Cefepime UNII I8X1O0607P - CEFEPIME HYDROCHLORIDE
	Cefepime is a broad-spectrum, bactericidal antibiotic, with activity against a wide range of Gram-positive and Gram-negative bacteria, including many strains resistant to aminoglycosides or third generation cephalosporins. It has a reduced affinity for beta-lactamases.
	Read more about Cefepime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100592	Powder for injection	Synofepim Powder for Injection INJ_PWD 1 g 1 X 1 VIAL	126 NF-PP-198860 Synofepim Powder for Injection (Cefepime 1g) CEFEPIME 1G Each Vial Contains: Sterile Cefepime Hydrochloride USP Eq. To Cefepime 1000 mg (Sterile mixture of Cefepime Hydrochloride and L-Arginine) Drugs Imported Products 1 X 1 VIAL Prescription Only Medicine (POM) 2/22/2021 Synergy Specialty Ltd, Plot 11 Opic Estate, Channels Avenue, Off Lagos-Ibadan Expressway, Isheri-North. 8033029595 maadeoti@yahoo.com JFL LIFE SCIENCES PVT. LTD., PLOT NO 615, GIDC, KERALA ( BAVLA) DIST.-AHMEDABAD - 382245, GUJARAT STATE, INDIA., India	30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DE01	Cefepime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DE Fourth-generation cephalosporins
Discover more medicines within J01DE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100592